Experience with the fixed combination of benzoyl peroxide and clindamycin in acne therapy
- Authors: Verchoumova A.A.1, Khairutdinov V.R.1,2, Telichko I.N.2,3
-
Affiliations:
- S.M. Kirov Military Medical Academy
- The Institute of Medical Education at the V.A. Almazov Scientific Research Centre
- Dermatovenerological Dispensary No. 4
- Issue: Vol 100, No 1 (2024)
- Pages: 56-62
- Section: ORIGINAL STUDIES
- URL: https://ogarev-online.ru/0042-4609/article/view/254521
- DOI: https://doi.org/10.25208/vdv16050
- ID: 254521
Cite item
Full Text
Abstract
Background. Acne is one of the most common dermatoses, affecting more than 9% of the world’s population. Acne negatively affects the patient’s quality of life and self-esteem, often leading to the development of anxiety and depression. The combination of pharmacological drugs with different mechanisms of action in one external dosage form can provide higher therapeutic efficacy.
Aims. To evaluate the effectiveness and tolerability of a combination drug with a fixed dose of clindamycin 1% and benzoyl peroxide 5% in the treatment of patients with mild to moderate papulopustular acne.
Methods. A single-center, open-label, observational, prospective study lasting 6 weeks was performed, which included 40 patients with mild to moderate papulopustular acne who received a gel with a fixed dose of clindamycin 1% and benzoyl peroxide 5% once a day. A clinical assessment of the effectiveness of therapy was carried out, PH, greasiness and moisture of the facial skin were measured, and the dynamics of the dermatological quality of life index was studied.
Results. The proportion of patients who showed significant improvement at the end of 6 weeks of treatment was 32/40 (80%). The total proportion of patients who showed significant and moderate improvement at the end of therapy reached 36/40 (90%).
Conclusion. The results obtained showed the high therapeutic effectiveness of the gel with a fixed dose of clindamycin 1% and benzoyl peroxide 5% in the treatment of mild to moderate papulopustular acne.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anna A. Verchoumova
S.M. Kirov Military Medical Academy
Author for correspondence.
Email: anna.chernyshova2307@ya.ru
ORCID iD: 0000-0002-3360-2046
MD, Resident
Russian Federation, Saint PetersburgVladislav R. Khairutdinov
S.M. Kirov Military Medical Academy; The Institute of Medical Education at the V.A. Almazov Scientific Research Centre
Email: haric03@list.ru
ORCID iD: 0000-0002-0387-5481
MD, Dr. Sci. (Med.), Assistant Professor
Russian Federation, Saint Petersburg; Saint PetersburgIgor N. Telichko
The Institute of Medical Education at the V.A. Almazov Scientific Research Centre; Dermatovenerological Dispensary No. 4
Email: itelichko@yandex.ru
ORCID iD: 0000-0001-7544-654X
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint Petersburg; Saint PetersburgReferences
- Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021;326(20):2055–2067. doi: 10.1001/jama.2021.17633
- Самцов А.В., Аравийская Е.Р. Акне и розацеа: монография. М.: Фармтек; 2021. 400 c. [Samtsov AV, Araviiskaya EA. Akne i rozacea. Monografiya (Acne and rosacea. Мonography). Moscow: Farmtec; 2021. 400 p. (In Russ.)]
- Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33. doi: 10.1016/j.jaad.2015.12.037
- Gollnick HP. From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol. 2015;29(Suppl 5):1–7. doi: 10.1111/jdv.13186
- Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021;32(3):277–285. doi: 10.1080/09546634.2019.1654075
- Dreno B, Pecastaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32(Suppl 2):5–14. doi: 10.1111/jdv.15043
- Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106(1):176–182. doi: 10.1111/1523-1747.ep12329907
- Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105–1113. doi: 10.1111/j.1365-2133.2005.06933.x
- Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin Cosmet Investig Dermatol. 2015;8:371–388. doi: 10.2147/CCID.S69135
- Tan JKL, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3–12. doi: 10.1111/bjd.13462
- Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA, et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis. 2001;67(2):165–169.
- Green L, Cirigliano M, Gwazdauskas JA, Gonzalez P. The Tolerability Profile of Clindamycin 1%/Benzoyl Peroxide 5% Gel vs. Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel for Facial Acne: Results of Two Randomized, Single-Blind, Split-Face Studies. J Clin Aesthet Dermatol. 2012;5(5):16–24.
- Thiboutot DM, Dreno B, Abanmi A, Alexis AF, Araviiskaia E, Cabal MIB, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1–S23.e1. doi: 10.1016/j.jaad.2017.09.078
- Аравийская Е.Р., Самцов А.В., Соколовский Е.В., Бакулев А.Л., Мурашкин Н.Н., Карамова А.Э. К вопросу об оценке по степени тяжести и классификации акне. Вестник дерматологии и венерологии. 2022;98(6):48–54. [Araviiskaya ER, Samtsov AV, Sokolovsky EV, Bakulev AL, Murashkin NN, Karamova AE. Revisiting the question of assessment by severity and classification of acne. Vestnik Dermatologii i Venerologii. 2022;98(6):48–54. (In Russ.)] doi: org/10.25208/vdv1374
Supplementary files
